Incretins (GLP-1 receptor agonists and dual/triple agonists) and the liver-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Incretins (GLP-1 receptor agonists and dual/triple agonists) and the liver

Published:2023-12 Issue:6 Volume:79 Page:1557-1565
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Newsome Philip N.^ORCID,Ambery Phil

Funder

University of Birmingham

University Hospitals Birmingham NHS Foundation Trust

Birmingham Biomedical Research Centre

Manchester Biomedical Research Centre

National Institute for Health and Care Research

Publisher

Elsevier BV

Subject

Hepatology

Reference52 articles.

1. A multi-society Delphi consensus statement on new fatty liver disease nomenclature;Rinella;J Hepatol,2023

2. Decreased hypothalamic glucagon-like peptide-1 receptor expression in type 2 diabetes patients;Ten Kulve;Clin Endocrinol Metab,2016

3. Tanycytes control hypothalamic liraglutide uptake and its anti-obesity actions;Imbernon;Cell Metab,2022

4. Exenatide regulates cerebral glucose metabolism in brain areas associated with glucose homeostasis and reward system;Daniele;Diabetes,2015

5. Brain reward-system activation in response to anticipation and consumption of palatable food is altered by glucagon-like peptide-1 receptor activation in humans;van Bloemendaal;Diabetes Obes Metab,2015

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adipocyte inflammation is the primary driver of hepatic insulin resistance in a human iPSC-based microphysiological system;Nature Communications;2024-09-12

2. GLP1 agonists: current and future landscape of clinical trials for patients with metabolic dysfunction;Nature Reviews Gastroenterology & Hepatology;2024-09-06

3. Preclinical modeling of metabolic syndrome to study the pleiotropic effects of novel antidiabetic therapy independent of obesity;Scientific Reports;2024-09-05

4. Targeting mitochondrial homeostasis in the treatment of non-alcoholic fatty liver disease: a review;Frontiers in Pharmacology;2024-09-03

5. Glucagon-Like Peptide-1 Receptor Agonists for Treatment of Steatotic Liver Disease in Patients With Type 2 Diabetes Mellitus: Growing Evidence But Not Yet There;Gastroenterology;2024-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3